首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Oncogenesis

缩写:ONCOGENESIS

ISSN:2157-9024

e-ISSN:2157-9024

IF/分区:6.4/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引958
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Kim Lucia Schneider,Luisa Claus,Richard Bucala et al. Kim Lucia Schneider et al.
Survival rates for patients with late-stage colorectal cancer (CRC) remain low due to limited efficacy of current therapeutic regimens. To overcome these challenges, novel drug targets are urgently needed. Macrophage migration inhibitory fa...
Yantang Lin,Christelle Dubey,Tereza Losmanova et al. Yantang Lin et al.
Pleural mesothelioma (PM) is an aggressive, asbestos-linked cancer with limited treatment options and a poor prognosis. Lactate dehydrogenase B (LDHB) converts lactate to pyruvate, and its silencing reduces mitochondrial metabolism, particu...
Md Mohiuddin,Vanda Póvoa,Rita Fior et al. Md Mohiuddin et al.
The oncogenic BRAF(V600E) mutation activates the ERK1/2 pathway and is detected in 10% of human colorectal cancers (CRCs) where it is associated with poor prognosis. Inhibitors of BRAF have shown only modest efficacy in patients with CRC du...
Yen-Ju Lin,Yu-Cheng Wu,Yu-Jui Liu et al. Yen-Ju Lin et al.
Squamous cell carcinoma (SCC) poses a significant global health challenge due to the lack of effective treatments. Boron neutron capture therapy (BNCT), a targeted particle therapy, has shown promising results in various cancers. SLC7A5, a ...
Chaehyun Yum,Richard A Schaefer,Rui Wang et al. Chaehyun Yum et al.
It is well established that EZH2, a lysine methyltransferase, is upregulated in most aggressive cancers, highlighting the importance of EZH2 in cancer progression. Recent research has shown that metabolic reprogramming is pivotal in various...
Le Zhang,Lidia Atencia Taboada,Selami Baglamis et al. Le Zhang et al.
BCL-XL is a crucial anti-apoptotic protein that supports survival of intestinal cells during the progression and in established colorectal cancer (CRC). While targeting BCL-XL with BH3 mimetics is effective, its significant toxicity highlig...
Yi-Hui Wu,Pei-Ying Wu,Yu-Fang Huang et al. Yi-Hui Wu et al.
Biomarkers that predict disease progression may assist in the development of better therapeutic strategies for aggressive cancers, such as ovarian cancer. This study aimed to investigate the role of collagen type IV alpha 6 (COL4A6) in cell...
Bhawna Deswal,Sameera Nallanthighal,Elahe Nikpayam et al. Bhawna Deswal et al.
Lipid droplet-associated hydrolase (LDAH) is a lipid hydrolase abundantly expressed in adipose and ovarian tissues and macrophages. However, LDAH's functions in ovarian cancer are largely unknown. Analysis of publicly available patient data...
Chen-Li Zhang,Chan-Yuan Zhao,Jia-Ming Dong et al. Chen-Li Zhang et al.
Extracellular vesicles (EVs) play a pivotal role in intercellular communication and are closely linked to cancer progression and metastasis. Our previous studies have shown that gastric cancer cell-derived EVs can promote tumor metastasis b...
Hui-Ching Chuang,Ming-Hsien Tsai,Jiin-Haur Chuang et al. Hui-Ching Chuang et al.
Head and neck squamous cell carcinoma (HNSCC) remains a prevalent and challenging cancer to treat due to its genetic heterogeneity. Cisplatin resistance is one of important causes in treatment failure of locally advanced HNSCC. ONC201, a se...